Venture
Deep-Tech Lab Ventures
Joining DTL will give you an opportunity to work with acclaimed scientists and researchers as well as tech entrepreneurs. DTL is dedicated to assist founders to build scalable, science and technology based startups at seed stage. This year, we have eight deep-tech ventures graduated from the inaugural cohort. Through the DTL program, these graduated ventures have successfully expanded their market opportunities.
To support more founders, DTL also provides opportunities to our associate members for seeking advice and expand their networks via the DTL sessions.
Success Stories
We’ve empowered companies from recent cohorts to develop products, go to market, forge partnerships, scale globally and secure investments. Below are highlights of our collaborations:
Featured Companies
1. Meat the Next (Sustainable Food Tech) – entered retail market and raised funding
2. Nexodata (Network Coding and Secret Sharing Algorithm) – raised seek funding and entered the North American market
3. Kodifly (Digital Twins Solutions with LiDAR Technology) – gained clear strategic direction and raise first investment
4. Focus Tech – finished the prototype and obtained an agreement from a firm to license its produce
5. Exotech (Exoskeleton Solutions) – multiple prototype development and testing with manufacturer partners
6. Orange Biotech (Point of Care Testing Innovation) – focusing on food testing in partnership with CMA+, which is a technology commercialization platform in HK
7. Nutrigene AI (Drug Screening and Cell-based Therapies) – developing first product on skin-care
8. Hanzhida (AI-powered Smart Manufacturing Solutions) – successful go-to-market and planning for fund-raising
9. LeafIoT Technology Company(Smart Agricultural IoT Solutions) – found and secured overseas clients and planning for fund-raising
10. Codex Energy (High Performance Computing Data Center using flare gas from oil fields) – raised seed funding and installed products to two sites
Key Achievements:
- Go-to-Market: Exploring creatively to came up with viable beachhead market.
- Strategic Partnerships: Connected companies with manufacturers and distributors to amplify product reach.
- Global Expansion: Supported market entry strategies for international scalability.
- Investor Readiness: Refined pitch decks and business models to attract venture capital and strategic investors.
- Funding Opportunities: Facilitated introductions to investors, resulting in seed rounds and Series A funding.
- Leadership Enhancement: Recruited seasoned executives to optimize operations and drive growth.
By aligning innovation with execution, we’ve enabled these startups to transform vision into tangible success.
DTL 2025-26 Ventures
Elevatefoods Technology Limited
Elevatefoods is a start up with the vision to revolutionize personalised clinical nutrition and digitally optimised food. Elevatefoods’ mission is to develop a commercially viable integrated smart streamlined 3D food fabrication technology that changes the way personalized foods are prepared, cooked, and experienced, hence delivering ready-to-consume edible products with unique design profiles including textural, sensory and nutritious profiles.
Jelumiere Biotech Limited
Jelumiere Biotech Limited is a company focusing on biotechnology-driven skincare solutions, particularly innovative, hormone-free sunscreens and related products that promote safe, effective, and sustainable beauty. As the demand for effective sun protection rises, Jelumiere addresses major health concerns associated with existing sunscreens: chemical filters linked to endocrine-disrupting and carcinogenic effects, and physical sunscreens that offer only limited UV defense.
Cennano
CenNano Ltd. is a Hong Kong based biotechnology company. It operates in the field of life sciences and biomedical engineering, focusing on nano pore technologies. The company’s mission is to develop innovative biomedical engineering solutions for future healthcare and biotechnology. CenNano aims to make high-precision molecular diagnostics faster, more accessible and more affordable for healthcare, biotechnology, and food safety applications.
C2iVect Limited
C2iVect Limited is a spinout of the InnoHK-funded Centre for Immunology & Infection (C2i), bringing scientific depth and translational infrastructure from Hong Kong’s biomedical innovation ecosystem. C2iVect is developing a rapid, low-cost, and portable diagnostic kit for early dengue detection. It uses a molecular test to determine which dengue serotype a person is infected with, and a secondary test to assess their risk of severe disease based on their prior immune history. The kit is designed for hospitals, clinical, and field use, particularly in Southeast Asia and other tropical regions.
Mixcare Health
Mixcare Health's vision is to become Asia's leading digital platform for the health and wellness needs of employers, insurers, and their employees and policyholders. The company addresses a market gap in accessibility, digitalization, and personalization of health benefits. Its core solutions are: (1) Preventive Health Management Solution for Insurers: Providing insurance companies with an API-
enabled digital platform to offer health and wellness benefits, capturing unique health data for analysis; and (2) Employee Benefit Solution for Enterprises: Offering a customizable platform for enterprises to manage employee benefits, including a wellness marketplace, with a focus on improving engagement and satisfaction.
Sharpsight Limited
SharpSight Limited is a medtech company focusing on innovative rehabilitation solutions for neurological dysfunctions, leveraging AI, computer vision, and IoT technologies to provide full-cycle rehabilitation. Founded in Hong Kong by rehabilitation and engineering experts, the company emphasizes precise, personalized rehab through devices, AI algorithms, and a tracking platform (wehab®). It targets patients with conditions like stroke, chronic pain, and neurological disorders, offering both clinical and telerehabilitation options. SharpSight aims to empower clinicians and patients with standardized pathways, AI assessments, and remote monitoring, positioning itself in the growing neurorehabilitation market.
Exin Therapeutics
Exin Therapeutics, founded in 2024 and based in South San Francisco, has developed an AI-powered, multimodal drug-discovery platform targeting neural circuits implicated in neurological and neuropsychiatric disorders. Exin Therapeutics integrates high-density mouse neural activity, behavioral, and transcriptomic data to predict and prioritize therapeutic candidates. Their agnostic platform supports various modalities—gene therapy, RNA, or small molecules—and is initially focused on conditions like epilepsy (including ASD-associated epilepsy) and Parkinson’s disease, offering a circuit-centric alternative to traditional gene restoration approaches.
Cell Centrality Biotech Ltd
Cell Centrality Biotech (CCB) is a Shenzhen-based biotech startup pioneering stem cell therapies and banking for companion animals, especially dogs and cats. The company operates a GMP-compliant stem cell lab and offers both autologous (stem cells derived from the same animal) and allogeneic (stem cells sourced from a donor animal) stem cell treatments through veterinary partnerships. CCB leverages patented activation technologies to enhance stem cell efficacy and is positioning itself as a first mover in China’s emerging pet stem cell banking market.
ESF SynapseAI
ESF SynapseAI is an AI-driven educational technology initiative under the English Schools Foundation (ESF), focusing on developing intelligent tools to enhance teaching, learning, and student analytics in K-12 education. Based in Hong Kong, it aims to create a suite of AI products that integrate voice-to-data analytics, curriculum enrichment, and personalized learning diagnostics. The project is in the early prototype stage, with a vision to spin off subsidiaries by March 2026. ESF, established in 1967, is a well-established non-profit with over 18,000 students across its schools, providing a built-in testing ground for SynapseAI’s tools.
WiseForge Innovative Technologies Ltd.
WiseForge Innovative Technologies Ltd., through its WildlifeView.com platform powered by PeckPerk, is developing a Nature Explorer AIoT Platform designed to revolutionize the wildlife watching experience. The company’s overarching vision is to cultivate a profound connection between individuals and the natural world, fostering a harmonious ecosystem. This vision is underpinned by a mission to establish a vibrant community of nature enthusiasts, utilizing smart technology to facilitate the exploration and sharing of nature’s beauty, while simultaneously championing wildlife conservation and ecological restoration. The platform currently serves a substantial user base, reportedly encompassing tens of millions of users and supporting millions of devices.
AI-vBRAIN LIMITED
AI-vBrain is a Hong Kong-based medtech startup developing AI-powered brain health screening tools that enable rapid, non-invasive detection of cognitive disorders such as mild cognitive impairment, depression, and Alzheimer’s disease. Leveraging portable EEG technology and proprietary AI algorithms, the company’s core product delivers clinically validated results in just 10 minutes, designed for use in primary care, elderly care, and preventive health settings.
NerOcean Limited
NerOcean Limited (NerOcean) is a Hong Kong-based ocean technology company. We recognize the limitations of current ocean monitoring technologies. At NerOcean, we develop innovative sensing solutions using our proprietary chemical modification techniques to advance humanity’s understanding of marine ecosystems and protect public health through sustainable ocean management.
Homing Therapeutics
Homing Therapeutics is a Hong Kong-based biotech startup developing next-generation CAR T cell therapies designed to enhance treatment efficacy for blood cancers by enabling immune cells to effectively home to the bone marrow—a key reservoir for residual cancer cells and a common site of relapse. The company uses both genetic and chemical engineering strategies to redirect CAR T cells specifically to the bone marrow, addressing major limitations of existing therapies such as low tumor clearance, high relapse rates, and severe toxicity.
Aura Labs Limited
Aura Labs is a PropTech company dedicated to driving digital transformation in the real estate industry. Our mission is to help CRE enterprises unlock new value from their property assets through data. At Aura Labs, we are committed to measurable impact that enhances operational efficiency, enriches tenant and visitor experiences, and promotes sustainability within any built environment.
Aura Labs’ flagship product, SeerOS, is a next-generation building operating system that unifies building data, systems, and controls into a single platform to enable automation, real-time insights, and smarter facility management.
Exon Power System Limited
Exon Power System Limited is a company focusing on developing and commercializing advanced powertrain control systems for methanol-fueled CCHP applications, especially for industrial energy conservation and emission reduction. Launching Combined Cooling, Heat and Power (CCHP) system, targeting on sustainable power solutions, particularly in regions like Hong Kong, Europe, and Southeast Asia. It is a control system for CCHP units powered by methanol, enabling combined generation of electricity, heating, and cooling. The system includes patented engine control technologies for small-to-medium engines, customizable versions tailored to investor needs, and supporting assets like test data and market research.
Bonbon-X Limited
Bonbon -X Limited is a Hong Kong–based robotics firm, founded in 2020, specializing in the design and development of autonomous underground inspection robots primarily for narrow-diameter pipelines that are too small or hazardous for human entry. Their mission is to replace manual confined-space inspections with safe, efficient robotic surveys that leverage dual-camera systems (CCTV + infrared) to detect structural issues early and help maintenance teams prepare and intervene effectively
CodeLife AI
CodeLifeAi is a next-generation biotechnology platform focused on enhancing design, analysis, and innovation in protein engineering, gene editing, and synthetic biology. Its vision is to revolutionize biotechnology by providing advanced tools to accelerate discovery.
Its AI platform is a smart, user-friendly tool that uses artificial intelligence to make biology research easier. It brings together several AI helpers to simplify tasks like designing DNA, searching for biological information, checking for accuracy, and creating lab experiment plans.
Incando Therapeutics
Incando Therapeutics Pte. Ltd. is a company focusing on developing light-based therapies for intractable cancers, particularly Glioblastoma multiforme (GBM), and neurodegenerative diseases such as Parkinson’s and Alzheimer’s. Incando Therapeutics is developing a unique medical device-based phototherapy system for the treatment of Glioblastoma multiforme (GBM), a devastating and fatal cancer of the brain. Patented wireless powering technology enables our Deeplight Photodynamic therapy to be used repeatably and with a better safety profile than current chemoradiotherapy treatments.
Gynaesolution Limited
Gynaesolution Limited is a startup focused on women’s health, particularly addressing gynecological issues like menstrual pain and endometriosis. It is developing evidence-based, non-hormonal, and fertility-preserving therapies that aim to outperform existing hormonal treatments, which are often associated with bone loss and high recurrence rates. With IP-protected compounds, AI-driven drug repurposing, and partnerships with academic and industrial players, Gynaesolution is positioned to redefine gynecological care through scalable, globally relevant
therapeutics.
DTL 2024-25 Graduated Ventures
Dynamic Vacuum Technology Corp.
We make vacuum pumps using our revolutionary design to create scalable and profitable business. A breakthrough in vacuum pump for semiconductor manufacturing that is reliable, cost-effective, energy-efficient and able to increase overall production yield at a fraction of the lifetime costs.
Illuminatio Medical Technology Limited
Illuminatio Medical Technology Limited (IMT) focuses on innovative diagnostic imaging. Addressing gaps in chronic liver disease (CLD) diagnosis, IMT develops non-invasive technology to replace costly, invasive liver biopsies, offering a comprehensive solution for diagnosing and monitoring liver fibrosis, impacting 1.5 billion people worldwide.
NutrigeneAI Biotech Limited
NutrigeneAI Biotech Limited (NBL) is dedicated to revolutionizing vascular healthcare through advanced biotechnology solutions. Our business model is structured around two primary service pipelines: drug screening and cell-based therapies.
Hanzhida
Hanzhida empowers manufacturing industry for intelligent process transformation with advanced software applications that exploit manufacturing data with industry-leading AI and feature recognition technology.
LeafIoT Technology Limited
LeafIoT Technology Limited is a pioneering company dedicated to transforming urban forestry management through innovative technology. Our flagship product, LiFY-T, is the world's first AIoT Urban Forest Health and Risk Monitoring Solution, designed with a similar working principle to an ECG, evaluating the "heartbeat" of trees to assess their health and predict risks.
PV2+ GmbH
PV2+ GmbH is a deep-tech spin-off from the Fraunhofer Institute for Solar Energy Systems ISE. Within the institute the team of PV2+ has developed a patented the core technology of PV2+. This technology is a cost-effective, environmentally friendly electroplating process, that allows to replace costly and scarce silver for the electrical contacts of solar cells with affordable and abundant copper.
DTL 2023-24 Graduated Ventures
Astra Optics Limited
Astra Optics Limited, founded by a team of experts in optical engineering, material science, and nanomanufacturing, is a spin-off company from the Chinese University of Hong Kong. Our ground-breaking 3D nanofabrication technology, i.e., femtosecond projection laser patterning system and hydrogel-based multi-material fabrication platform, has proven records to revolutionize the micro-additive manufacturing industry by overcoming critical bottlenecks in current state-of-the-art solutions, namely, low-throughput and high fabrication cost.
.png)
Gut Rhythm R&D (Hong Kong) Limited
Gut Rhythm is a research team spin-off from the Chinese University of Hong Kong. Gut Rhythm provides drug-testing service and subscription service (to-be-launched) to our standardized and sustainable "electrical" drug databases. Drug-testing service will test clients’ drug-of-interest using our protocol (IP at CUHK, US and China patent in progress) of gastrointestinal slow-wave network analysis to create unique electrophysiological drug profiles. Self-developed automatic analytical pipeline allows maximum speed to create comprehensive drug testing report in 1 day.
Meat the Next
Meat the Next is a superfood technology company focused on creating delicious and nutritionally balanced New Proteins products to fight for climate change from diet change. Through patented technologies and unique raw materials like non-GMO Soy & Tiger Nuts, we offer dairy-free products enhancing taste and texture. We have developed the World's First Tiger Nut Oat Soy Milk with market recognition. We differentiate our products and overcome existing market barriers to provide an indulgent and sustainable eating experience to our esteemed customers.
Provectus Therapeutics
Provectus Therapeutics is a biotech company, spin-off from CUHK, aiming to develop advanced single cell analytic AI platform to empower Precision Oncology Research, Novel Drug Development and Personalized Cancer Treatment Prediction for each cancer patients, by implementing the state-of-the-art technologies. We apply Artificial Intelligence and Microfluidics to develop the advanced single cell culture platform for high throughput drug screening analysis. Ultimately, our platform will be applied in Precision Oncology Research, New Drug Development and Personalized Treatment for each cancer patient.
.png)
Codex Energy
Codex Energy develops High-Performance Computing (HPC) datacenters and the energy systems to power them. Utilizing stranded natural gas as a carbon negative energy source, Codex provides and operates infrastructure for Bitcoin mining and AI/ML compute applications. Our vertically integrated, full-stack immersion cooling, power systems, and cloud-based automation and systems management technologies are all developed in-house and enable our HPC datacenters to operate continuously in the harshest off-grid environments.
Kodifly Limited
Kodifly specializes in advanced spatial intelligence and transport infrastructure monitoring. We focus on creating real-time digital twins using cutting- edge LiDAR technology, delivering actionable insights for infrastructure challenges like deformation, landslides, and vegetation encroachment through precise 3D point cloud processing. Our solutions prioritize the safety and longevity of essential transport infrastructure such as airports, railways, and highways, emphasizing climate resilience.
Nexoedge
Nexoedge is the research result by The Chinese University of Hong Kong (CUHK) which joined LF Edge as the Associate Member in early 2023. Nexoedge uses Network Coding and Secret Sharing algorithms to shard data into any number of components during data transmission from edge to cloud, thus enabling a secure platform for efficient information transmission and storage. Sharded data can be stored in multiple clouds without any need for data replication, resulting in increased data availability, enhanced protection on data privacy and security, and fault-tolerant storage.
.png)
PuroChem Limited
PuroChem Limited is a biotech startup, built on the patent protected technology platform, Dispersed Mobile-phase Countercurrent Chromatography (DMCC), developed at Hong Kong University of Science and Technology (HKUST). PuroChem, as a spin-off of PharmacoGenetics Limited, which is an innovation- driven biopharmaceutical company partly owned by HKUST R&D Co., is born as the champion, for original brand design and production of DMCC equipment, enabling highly scalable, cost- effective and environmentally friendly purification of therapeutics and nutraceuticals, increasingly needed for our aging society.
DTL Associate Members
Focus Tech (1st Cohort)
Focus Tech is an AI technology company that specializes in computer vision algorithms with applications in healthcare and education. In healthcare, our technology enhances medical imaging and diagnostics, enabling accurate disease diagnosis, treatment tracking, and personalized care. In education, our algorithms provide personalized learning paths, adaptive assessments, and interactive content, improving educational outcomes and engagement.
Additionally, our expertise in eye tracking and motion detection facilitates assistive technologies, immersive virtual experiences,
and gesture-based control systems. By commercializing our technology in these sectors, we aim to revolutionize healthcare delivery, transform education, and make a positive impact on society.
Juyan Intelligence Technology Co., Ltd. (1st Cohort)
Juyan Intelligence is a controlling subsidiary of Juyan Technology and boasts a top-tier artificial intelligence algorithm team (the only Chinese lead scientist in Amazon, the president of CVPR). We are dedicated to solving the high-risk sports project and drowning problems in swimming venues through AI technology.
Our system "AI Safety Eye"AI Drowning Prevention Innovation System uses the most advanced AI technology being developed worldwide. It is the first system in the world to use a top-mounted camera to replicate a lifeguard's perspective, and through a computer's powerful calculation and long-term deep training, it integrates the visual features and thought patterns of lifeguards to judge dangerous incidents.
OAO Limited (1st Cohort)
OAO aims to revolutionize the field of AI in 3D space, and making information more accessible to everyone. Our flagship project – GIMII, is a 3D anatomy platform for medical education. It offers effortless scanning and 3D model generation, allowing users to capture objects and environments through a simple smartphone application, transforming them into high-fidelity 3D models in minutes.
ExoTechHK specializes in developing next generation wearable AI-embodied exoskeleton as a generic solution to satisfy the interaction demands of daily work and life, including supporting labour working, assisting daily movements, protect and enhancing exercise, and empowering development of innovation interaction solutions for other daily demands.
Health View Bioanalytic Limited (2nd Cohort)
Health View Bioanalytic Limited (“HVB”) is a start-up that put state-of-the-art research into reality by accurately assessing the risk of stroke through a fundus photo in the fastest and convenience manner.
Developed through cutting-edge researches from the CUHK, the Automatic Retinal Image Analysis (“ARIA”) system provides stroke risk assessment for patients not limited to high risk patients with diabetes, heart disease or hypertension.
Orange Biotech (2nd Cohort)
Orange Biotech is a reagent company specializing in exclusive CRISPR technology and microfluidics. Our mission is to become a comprehensive Point of Care Testing (POCT)company, providing accessible and affordable diagnostic solutions for home-based nucleic acid tests not limited to disease confirmation, but also in disease prevention and re-examination afterdrug treatment.
RevAge (2nd Cohort)
RevAge (Centre for Translational Stem Cell Biology) presents an "ageing-emulated biosystem" leveraging patented human trophoblast stem cell (hTSC) technology. Within a week, hTSCs mature into aged cells, mimicking natural ageing. This system provides a rapid, accurate, and quantitative model for studying ageing and evaluating anti-ageing treatments, setting a potential gold standard for in vitro research.
FutuRocket Co. (1st Cohort)
Working with Earth Corporation, one of the world's largest insecticide company in Japan,
FutuRocket makes training data for AI that can detect cockroaches and mice by using their lab breeding cockroaches and mice.
FutuRocket also focuses on creating an affordable, easy-to-install analytics platform for physical spaces. We are developing a smart camera for small businesses, named "ManaCam”.
"ManaCam" is a smart camera for small businesses. It is a simple, easy to use smart camera. No engineering knowledge is necessary, you can automatically start to count the number of visitors, customers coming to your shops and spaces..
MIND and Tech Limited (1st Cohort)
MIND and Tech Limited is an innovative biotechnology company developing novel magnetic nanoparticle-based tools for Medical Imaging and Nano Diagnostics. Our company provides a cost-effective, simple, direct yet sensitive platform for early neurodegenerative diseases detection and diagnostics.
Recently, we are focusing on the development of a set of Alzheimer's disease biomarkers detection kits including beta-amyloid (1-42), beta-amyloid (1-40), total-tau (441) protein and phosphate-tau (181) protein for laboratory use. Benefiting from our designed fluorophore, it is an ultra-highly sensitive and non-invasive validate test for biomarkers-related disease in trace amounts of several body fluids including CSF, blood, saliva and urine. It can apply as a screening tool to detect and diagnose Alzheimer's disease in an early stage.
Chemmino focuses on integrating advanced multispectral sensors into portable spectral devices, combined with leading DNA damage biomarkers, to provide the public with an accessible early disease screening solution through an accurate and rapid AI-based cancer risk assessment model. Our goal is to serve a broader audience by developing and commercializing more sensitive, portable, and inclusive early cancer screening solutions.
FinFAST (2nd Cohort)
FinFAST is an AI-powered one-stop integrated platform designed for financial institutions, governments, and NGOs. By incorporating patented example-based search, deep learning such as large language models (LLMs), and econometric techniques, FinFAST provides secure, reliable, and automated searching, analysis, modeling, and prediction based on financial data and text.
i-RNA Corporation (2nd Cohort)
i-RNA Corporation is an early-stage spin-off company from the University of Western Ontario, that is dedicated to the development of innovative methods for the treatment and diagnosis of diabetic retinopathy (DR), a leading cause of blindness worldwide affecting millions of patients.
Skybotics Technology Limited (2nd Cohort)
AIR (Aerial universal Robot) is an innovative contact-based drone for building operations. Affordable and lightweight, AIR excels in chaotic site environments with minimal setup. It performs tasks like seepage detection (AIR-Moist) and hammer-tapping inspection (AIR-Hammer), offering safe, efficient building maintenance without gondolas or scaffolding.
PharmaEase Tech Limited (2nd Cohort)
PharmaEase is a silica-based solubility enhancement technology intended for orally delivered small molecule drugs. PharmaEase is an ‘inactive’ substance that serves as a vehicle or medium for an active pharmaceutical ingredient (API). PharmaEase has superior solubility enhancing properties compared to existing silica-based market solutions, universally applicable to many drugs, and cost effective.